Survival

ACS Report: Five-Year Relative Survival Rates for All Cancers Up to 70 Percent in the U.S.

Physician’s Briefing

ACS Report: Five-Year Relative Survival Rates for All Cancers Up to 70 Percent in the U.S.

13 Jan 2026

1 min read

Benefit of Retention on MOUD Treatment Lasts for at Least Four Years

Physician’s Briefing

Benefit of Retention on MOUD Treatment Lasts for at Least Four Years

09 Jan 2026

1 min read

New Tool Assesses Recurrence Risk With Pancreatic Neuroendocrine Tumors

Physician’s Briefing

New Tool Assesses Recurrence Risk With Pancreatic Neuroendocrine Tumors

30 Dec 2025

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com